Plethico Pharmaceuticals Ltd - PLETHICO PHARMA. Share Price

Sector: Pharmaceuticals | ISIN: INE491H01018
₹ 9.05 (-4.74%) icon13 Jun, 2016, 12:00:00 AM
Open
₹ 9.05
Prev. Close
₹ 9.50
Turnover(lac)
₹ 0.00
Day's High
₹ 9.05
Day's Low
₹ 9.05
52 Wk High
₹ 0.00
52 Wk Low
₹ 0.00
Book Value
₹ 77.79
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 30.83
P/E
0.59
EPS
13.49
Div. Yield
0.00

Plethico Pharmaceuticals Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 6/13/2016 12:00:00 AM

    ₹ 9.05 -0.45 -4.74
  • Open
  • ₹ 9.05
  • Prev. Close
  • ₹ 9.5
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 9.05
  • Day's Low
  • ₹ 9.05
  • 52 Week's High
  • ₹ 0
  • 52 Week's Low
  • ₹ 0
  • Book Value
  • ₹ 77.79
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 30.83
  • P/E
  • 0.59
  • EPS
  • 13.49
  • Divi. Yield
  • 0

Plethico Pharmaceuticals Ltd Corporate Actions

No Record Found


Plethico Pharmaceuticals Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Plethico Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
25 April , 2024 | 11:54 AM

PROMOTER - TOTAL57.75%

Indian: 57.75%

Foreign: 0%

NON-PROMOTER - TOTAL 42.25%

Institutions: 19.41%

Non-Institutions: 22.84%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Plethico Pharmaceuticals Ltd FINANCIALS

Plethico Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Plethico Pharmaceuticals Ltd

  • Shashikant Patel
  • Chairman & Managing Director
  • Pranav Koshal
  • Additional Director
  • Jignesh Jitendra Panchal
  • Additional Director
  • Milindkumar Laxmishankar Dixit
  • Additional Director

Summary

Plethico Pharmaceuticals Limited (PPL), an emerging global healthcare company was incorporated on 4th December 1991 as a private limited. PPL is engaged in the business of manufacturing, marketing and distribution of a broad range of pharmaceutical and allied healthcare products, with operations in several key markets in India and internationally. Domestically, Plethico operates in the segments of Sports Nutrition, Confectionary and OTC, in India. The companys robust product portfolio includes renowned, international brands such as Herbal healthcare products, Food Supplements and Pharma OTC. PPL having its presence in more than 60 countries including India, adding US, UK, Australia, Korea & HK recently after acquiring Natrol and the distribution focus in US, UK, CIS and deepening reach in SEA in Cambodia, Vietnam & Philippines. The Companys status and name was changed in the year 1992, converted from private limited to public limited company, consequent to change, the word private was deleted in the name and was rebuild to the present name Plethico Pharmaceuticals Limited from Plethico Pharmaceuticals Private Limited. Subsequently, the company had received the fresh incorporation certificate on 27th August 1992. During the period from inception to the year 2000, PPL had introduced the novel herbal products for Hepatocare, Diabetes and Syndrome X developed with in-house research and clinical evidence and also committed with major thrust into International Marketing. Travisil,... Read More


Reports by Plethico Pharmaceuticals Ltd


Reports by Plethico Pharmaceuticals Ltd

Company FAQ

No Record Found